Kromek Group (KMK) Trading Update summary

Strategic progress and partnerships

• Achieved significant strategic milestones in both Advanced Imaging and CBRN Detection segments, marking FY 2025 as a transformational year.

• Secured a major partnership with Siemens Healthineers, receiving an initial $25 million payment out of a $37.5 million total, boosting Advanced Imaging revenue.

• Signed two milestone agreements with UK Government entities for nuclear security technologies, including a contract with the UK Ministry of Defence.

• Selected as a supplier under a four-year UK Government framework contract, with initial orders expected in the current financial year.

• Expanded global presence with multiple orders from US and European customers in H2 2025.

Financial performance and outlook

• FY 2025 revenue expected to exceed £26 million, at least 34% year-on-year growth, ahead of market expectations.

• Profit before tax anticipated to be slightly ahead of market expectations.

• Group debt reduced to £0.5 million as of 30 April 2025, down from £12.3 million at 31 October 2024.

• Net cash position expected to be in line with market expectations.

• FY 2026 outlook includes contracted revenue of approximately £20 million and a strong near-term pipeline, supporting continued revenue growth and profitability.

Segment performance and operational highlights

• Advanced Imaging segment saw significant revenue growth due to the Siemens Healthineers partnership.

• CBRN Detection segment rebounded in H2 2025, with revenues more than doubling compared to H1 2025.

• Continued delivery on multi-year bio-security contracts with UK and US government agencies.

• Enhanced financial position enabled pre-tax profitability for the first time.

• Strong visibility for FY 2026 with a healthy international sales pipeline and government frameworks.